Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
New research highlights importance of early years development on future wellbeing
General Research
25 November 2021
Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.
Study reveals ‘stop-eating’ response to DNA damage
General Research
24 November 2021
A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.
World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition
General Research
23 November 2021
Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.
Oxford-led research maps milestone stage of human development for the first time
General Research
18 November 2021
Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.
Overusing antibiotics? Find out with Antibiotic Footprint Calculator
General Research
18 November 2021
To help reduce the overuse of antibiotics, Oxford researchers today released a new, easy to use online tool – Antibiotic Footprint Calculator – that could make an important contribution in the fight against antimicrobial resistance (AMR), one of the world’s most significant emerging threats to public health.
$2m fund awarded for Oxford’s single-cell ancestry vaccine research
General Research
17 November 2021
The University of Oxford is to benefit from $2 million (£1.49 million) in funding from the Chan Zuckerberg Initiative (CZI) to investigate how our ancestry and diversity influence the way that vaccines work in our cells.
New research reveals link between ankle pain and onset of knee osteoarthritis
General Research
16 November 2021
A new study published in Osteoarthritis and Cartilage Open could help improve the lives of people at risk of developing knee osteoarthritis.
Global antibiotic consumption rates increased by 46 percent since 2000
General Research
16 November 2021
Antibiotic consumption rates grew by 46 percent after 2000, according to findings which also suggest lack of treatment access in some areas.
Oxford vaccine reaches two billion dose milestone
Coronavirus COVID-19 General Research
16 November 2021
Researchers explain how unprecedented manufacturing strategy provides a template for future global vaccine supply.
Arm and shoulder disability and pain after breast cancer surgery reduced by exercise
General Research
15 November 2021
The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after their operation, a new study has found.
Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map
General Research
12 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.
Ebola vaccine to begin human trials
Clinical Trials General Research
11 November 2021
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers – with the first vaccinations having already taken place.
New advanced analytics research to deliver next level of insights into COVID-19
Coronavirus COVID-19 General Research
11 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
Sustainable eating is cheaper and healthier - Oxford study
General Research
11 November 2021
Global study shows vegan and vegetarian diets cheapest option in high-income countries ‘£1 Chef’ Miguel Barclay backs study
Researchers uncover gene that doubles risk of death from COVID-19
Coronavirus COVID-19 General Research
8 November 2021
Scientists at Oxford University have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, partly explaining the excess deaths seen in some UK communities, and the impact of COVID-19 in the Indian subcontinent.
Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders
General Research
5 November 2021
An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.
Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK
General Innovation Research
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
General Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Oxford to work with Brazil to establish clinical research hub
General Research
2 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.